Results 131 to 140 of about 781,240 (247)

Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease. [PDF]

Pulm Circ
Sadushi-Koliçi R, Alajbegovic L, Gojic V, Skoro-Sajer N, Campean I, Shafran I, Mörtl D, Gerges C, Lang IM.   +8 more
europepmc   +1 more source

Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease. [PDF]

J Am Heart Assoc, 2021
Lteif C, Ataya A, Duarte JD.
europepmc   +1 more source

Integrating Patient‐Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide

Arthritis Care &Research, EarlyView.
Objective To support high‐quality, patient‐centered care for systemic lupus erythematosus (SLE), the American College of Rheumatology (ACR) developed evidence‐based measures incorporating clinical and patient‐reported outcome measures (PROMs). Using the Consolidated Framework for Implementation Research (CFIR), we conducted semistructured interviews ...
Catherine Nasrallah, Cherish Wilson, Christine Hariz, Christie M. Bartels, Shanthini Kasturi, Wambui Machua, Amy Bennett, Kate Chiseri, Allison Plitman, Starla Hairston Blanks, April Jorge, Patti Katz, Jinoos Yazdany, Shivani Garg   +13 more
wiley   +1 more source

Upfront Exercise Hemodynamic Phenotyping of Patients with Pulmonary Hypertension and Left Heart Disease Risk Factors: A Prospective Experience. [PDF]

CJC Open
Karvasarski E, Park J, Savaris S, Beale A, Wright SP, Bentley RF, Granton JT, Mak S.   +7 more
europepmc   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

Novelties in Pulmonary Hypertension Secondary to Left Heart Disease

Barcelona Respiratory Network Reviews, 2022
Juan J. Rodríguez-Arias, Eduard Solé-Gonzalez, Ana García-Álvarez   +2 more
doaj   +1 more source

Pulmonary Arterial Hypertension and Left Heart Disease Phenotype: A Challenging Crossroad. [PDF]

Cardiol Res
Scagliola R.
europepmc   +1 more source

Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease. [PDF]

Eur Radiol, 2022
Melzig C, Do TD, Egenlauf B, Partovi S, Grünig E, Kauczor HU, Heussel CP, Rengier F.   +7 more
europepmc   +1 more source

Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin, Dylan Hansen, Laura Ross, Gene‐Siew Ngian, Susanna Proudman, Gabor Major, Maryam Tabesh, Mandana Nikpour, Jennifer Walker, Lauren Host, Nava Ferdowsi, Alannah Quinlivan, Wendy Stevens, Joanne Sahhar, Diane Apostolopoulos   +14 more
wiley   +1 more source

Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease. [PDF]

Ann Nucl Cardiol, 2022
Ohira H, deKemp R, Kadoya Y, Renaud J, Stewart DJ, Davies RA, Chandy G, Contreras-Dominguez V, Pugliese C, Dunne R, Beanlands R, Mielniczuk L.   +11 more
europepmc   +1 more source